comunicacio

Researchers identify an effective therapeutic strategy against a subtype of melanoma currently with no treatment

Researchers have observed that, in the absence of glucose, tumor cells become sensitive to treatment with sorafenib, a drug that was approved years ago for other indications.

Researchers identify an effective therapeutic strategy against a subtype of melanoma currently with no treatment Read More »

Symposium on Tobacco Control organized jointly with the World Health Organization

During the day, the Tobacco Control Scale was presented which describes the actions taken for tobacco control implemented in the 27 countries of the European Union plus 10 non-EU countries and which places the Spanish State in a situation very similar to that presented in the last edition in the year 2019

Symposium on Tobacco Control organized jointly with the World Health Organization Read More »

Agreement to boost and consolidate the Innovation and Health BioCluster project

The town councils of L’Hospitalet and Esplugues, the Bellvitge University Hospital, the Bellvitge Biomedical Research Institute (IDIBELL), the Catalan Institute of Oncology (ICO), the Sant Joan de Déu Hospital and the University of Barcelona have signed an agreement to promote and consolidate the Innovation and Health BioCluster project.

Agreement to boost and consolidate the Innovation and Health BioCluster project Read More »

New mouse models boost personalized treatment research in endometrial cancer

To generate the new models a fresh biopsy of the original tumor was implanted into the same mouse tissue. This perfectly reproduces the original morphological and molecular characteristics, and therefore it anticipates the tumor evolution to choose the best treatment.

New mouse models boost personalized treatment research in endometrial cancer Read More »

The Prostate Cancer Group obtains a grant from USA Department of Defense federal funds

The Award from USA Department of Defense will fund a 3-year project to study the role of cancer cell chromatin on the landscape of prostate tumor immune microenvironment.

The Prostate Cancer Group obtains a grant from USA Department of Defense federal funds Read More »

Scroll to Top